PG treatment decreases HCC cell survival. by Po-Li Wei (292225)

Cardiac function assessed by echocardiography in Ang II–infused young (3 months) or old (18 months) WT and smcKlf5^−/− mice. by Dong Ma (584680)

Subjects:

TG6-44 treatment decreases A/X31-induced ROS in THP-1 cells. by Juan A. De La Cruz (11154187)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Cellular co-infection decreases the potential for superinfection. by Brigitte E. Martin (8366847)

The Intracellular level of FLASH decreases during apoptosis. by Song Chen (69646)

Effects of Cu (5 µM) pretreatment on Hcy-induced decrease in cell viability and LDH release. by Daoyin Dong (424519)

Decreased H4R expression in GCs. by Chao Zhang (51048)

IR decreases but does not arrest ATC growth. by Vlad C. Sandulache (515406)

RSV increases apoptosis but decreases ROS production. by Cristina Rojas (667363)

Inhibition of NADPH oxidase decreases the oxidative burst. by Pedro Paulo Carneiro (2164114)

Effect of decreasing infectious dose on virus shedding. by Anthony C. Marriott (111070)

Estimated trajectories of EQ-5D-5L summary score and EQ-VAS using generalized additive mixed model. by Somayeh Momenyan (10111603)

cAMP production is decreased in FX mice. by Daniel J. Kelley (35705)

“…(a) Mouse platelet RF is comparable in the absence of forskolin [t(6) = 0.99; p = 0.36] but significantly different between groups (GroupxStimulus:[F(1,12) = 7.56;p = 0.018]) in the presence of forskolin [t(6) = −2.62; p = 0.040]. …”

Decreased FOXP3 Treg induction in LAG-3 KO cells <i>in vitro</i>. by Nicholas M. Durham (174371)

miR-100 decreases tumor size. by Bahauddeen M. Alrfaei (484859)

<i>Syx5</i> suppression in <i>Drosophila</i> S2 cells decreases copper accumulation. by Melanie Norgate (234832)

Source data for Figs 1B, 1C, 1E, 1G, 2B, 2C, 2F, 2H, 3A, 3B, 3C, 3E, 4B, 4D, 4F, 4G, 5D, 5E, 6E, 6G, 7B, 7C, 7E, 7G, 7I, S1B, S1E, S1G, S2B, S3B, S3D, S4B, S5B, S6A, S6B, S7A, S7B,... by Hitoshi Tsugawa (296864)

Blood Pressure Control Has Improved in People with and without Type 2 Diabetes but Remains Suboptimal: A Longitudinal Study Based on the German DIAB-CORE Consortium by Ina-Maria Rückert (346617)

“…We included 4,683 participants aged 45 to 74 years with complete data and accounted for 1,256 participants who were lost to follow-up by inverse probability weighting.</p><p>Results</p><p>Mean systolic blood pressure decreased in all groups from baseline to follow-up (e.g. – 8.5 mmHg in those with incident T2D). …”

The characterization and the decreased toxicity of liposomal SANT75. by Yike Yuan (396954)